These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 4547258)

  • 1. Nature of von Willebrand factor: a new assay and a specific inhibitor.
    Sarji KE; Stratton RD; Wagner RH; Brinkhous KM
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):2937-41. PubMed ID: 4547258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D; Potter EV
    J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor.
    Allain JP; Cooper HA; Wagner RH; Brinkhous KM
    J Lab Clin Med; 1975 Feb; 85(2):318-28. PubMed ID: 234499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
    Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF
    J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities of factor VIII and platelet aggregation--use of ristocetin in diagnosing the von Willebrand syndrome.
    Weiss HJ
    Blood; 1975 Mar; 45(3):403-12. PubMed ID: 1078779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VIII/von Willebrand factor binding to von Willebrand's disease platelets.
    Gralnick HR; Williams SB; Shafer BC; Corash L
    Blood; 1982 Aug; 60(2):328-32. PubMed ID: 6807372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody nature of circulating inhibitor of plasma von Willebrand factor.
    Stratton RD; Wagner RH; Webster WP; Brinkhous KM
    Proc Natl Acad Sci U S A; 1975 Oct; 72(10):4167-71. PubMed ID: 812091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of inhibitory and binding characteristics of an antibody causing acquired von Willebrand syndrome: an assay for von Willebrand factor binding by antibody.
    Fricke WA; Brinkhous KM; Garris JB; Roberts HR
    Blood; 1985 Sep; 66(3):562-9. PubMed ID: 3927998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.
    Olson JD; Brockway WJ; Fass DN; Magnuson MA; Bowie EJ
    Am J Clin Pathol; 1975 Feb; 63(2):210-8. PubMed ID: 1078748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL; Kupinski JM; Castella A; Ruggeri ZM
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired von Willebrand's disease, platelet-release defect and angiodysplasia.
    Rosborough TK; Swaim WR
    Am J Med; 1978 Jul; 65(1):96-100. PubMed ID: 308316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An atypical von Willebrand's disease with hyperreactivity of platelet aggregation.
    Niiya K; Kubonishi I; Taguchi H; Miyoshi I
    Acta Haematol; 1984; 71(3):158-64. PubMed ID: 6424380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma aggregating factor (bovine) for human platelets: a marker for study of antihemophilic and von Willebrand Factors.
    Griggs TR; Cooper HA; Webster WP; Wagner RH; Brinkhous KM
    Proc Natl Acad Sci U S A; 1973 Oct; 70(10):2814-8. PubMed ID: 4542779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Von Willebrand's disease type B: a newly defined bleeding diathesis.
    Firkin B; Firkin F; Stott L
    Aust N Z J Med; 1973 Jun; 3(3):225-9. PubMed ID: 4125893
    [No Abstract]   [Full Text] [Related]  

  • 19. The relationship of the properties of antihemophilic factor (factor VIII) that support ristocetin-induced platelet agglutination (factor VIIIR:RC) and platelet retention by glass beads as demonstrated by a monoclonal antibody.
    Ogata K; Saito H; Ratnoff OD
    Blood; 1983 Jan; 61(1):27-35. PubMed ID: 6401215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.
    Barbui T; Dini E
    Acta Haematol; 1975; 53(1):44-8. PubMed ID: 807074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.